News Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial OfficerJuly 22, 2026 Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide TherapeuticsMarch 16, 2026 Novartis Bets Up to $1.7B in Cardio-Focused Peptide PartnershipFebruary 19, 2026 Argenx signs $1.5B pact to turn Unnatural Products' macrocyclic peptides to 'undruggable' targetsJuly 1, 2025 Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’January 23, 2024 Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and OncologyDecember 3, 2024
